|Articles|November 4, 2021
Pharmacy Clinical Pearl of the Day: Ectopic Pregnancy
Author(s)Saro Arakelians, PharmD
An ectopic pregnancy occurs when a fertilized egg implants and grows outside the main cavity of the uterus.
Advertisement
Clinical Pearl of the Day: Ectopic Pregnancy
An ectopic pregnancy most often occurs in a fallopian tube, which carries eggs from the ovaries to the uterus.
Insight:
- Pregnancy begins with a fertilized egg. Normally, the fertilized egg attaches to the lining of the uterus.
- An ectopic pregnancy occurs when a fertilized egg implants and grows outside the main cavity of the uterus.
- The patients may not notice any symptoms at first. However, some women who have an ectopic pregnancy have the usual early signs or symptoms of pregnancy—a missed period, breast tenderness, and nausea.
- If the patient takes a pregnancy test, the result will be positive. Still, an ectopic pregnancy can't continue as normal.
- First warning signs of an ectopic pregnancy are light vaginal bleeding and pelvic pain.
- Risk factors include previous ectopic pregnancy, inflammation or infection, fertility treatments, tubal surgery, birth control, and smoking
- Treatment would include methotrexate as an injection. Also, procedures such as laparoscopic salpingostomy and salpingectomy may be conducted.
Source:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
2
IMS 2025: Future Directions for CAR T Therapy in Relapsed and Refractory Multiple Myeloma
3
Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma
4
FDA Approves Bosaya and Aukelso, Biosimilars to Reference Denosumab
5